More PRNewswire
View Older Stories View Newer Stories-
Gale Miami Hotel and Residences Chooses Stayntouch to Power 688-Room Luxury Hybrid Aparthotel
-
Permanente Live Webinar on Keeping Patients and Clinicians Safe from Harm
-
BelliWelli Launches Into Walmart, Significantly Expanding Access to Digestive Healthy Snacks
-
LG LAUNCHES ITS 2024 FLAGSHIP SOUNDBAR
-
INTIMINA Shares What All Women Need to Know About Pelvic Organ Prolapse
-
Taking Charge: Geotab Report Unveils Significant Potential for Fleet Electrification with Insights from Over 1.3 million Vehicles
-
SportsGrid Launches Out-of-Home Content Solution on Barvanna Network
-
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
-
Woman's Life Insurance Society to Merge with Trusted Fraternal Life
-
Plusgrade and Royal Jordanian Airlines Announce Expanded Partnership to Elevate Royal Club Experience
-
Neuchips Driving AI Innovations in Inferencing
-
Boston Marathon® Jimmy Fund Walk Finish Line to Move to the Boston Common for 2024 Event
-
Splenda® is Awarding $2,500 to 25 Families in Honor of Its 25th Birthday to Support Families Impacted by Diabetes
-
One hundred days to the Games: Transport plan ready
-
Vericast Names In-Store Media Platform "nCountR," Set to Open "Market Experience" Demonstration Center this Fall
-
Hellmann's Takes Action to Save Mayo (and Our Sandwiches) from Extinction, Encourages Fans to Adopt Adorable Plushie Sandwiches
-
Syra Health and Maricopa County Partner for Third Public Health Training
-
Update regarding the Extrajudicial Reorganization Process
-
PeploBio and IncellDX Partner to Launch the First Long COVID Test in the UK and EU
-
Interpretation.ai - An AI Platform Solution for Oil and Gas Exploration
-
The Joint Chiropractic Proudly Supports Colorado-Based Rachel's Challenge
-
135th Canton Fair Showcases Innovations: A Stage for Cutting-Edge Tech Products
-
MISSISSIPPI LIME REBRANDS TO MLC, LAUNCHES NEW GLOBAL IDENTITY FOR THE FUTURE OF THE COMPANY AND UK SUBSIDIARY SINGLETON BIRCH
-
Nature's Miracle Holding Inc. and Agrify Corporation Agree to Merge
-
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
-
Natural Grocers® Honored at UNFI Circle of Excellence Ceremony at Expo West
-
PAN GLOBAL INTERSECTS 11 METERS AT 2.36G/T GOLD AND 22 METERS AT 0.41% COPPER, EXPANDING CAÑADA HONDA COPPER-GOLD DISCOVERY, SPAIN
-
illycaffè presents the new illy Art Collection at the Biennale Arte signed by 4 emerging Latin American artists
-
Peraton Supports Cyber ACCESSibility Expansion
-
Univar Solutions and ClearShift Take Steps to Advance Zero Carbon Specialty Chemicals
-
7-Eleven, Inc. Releases 2023 Impact Report: Another Year of Progress in Sustainability and Social Impact for the Global Convenience Retail Leader
-
Baidu Launches Second ERNIE Cup, A Global Innovation Challenge to Discover the Next Big AI-Native Applications
-
Empyrean Expands Public Sector Market Presence, Becoming a Benefits Administration Supplier to Sourcewell
-
Veeva Announces Vault CRM Campaign Manager
-
Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
-
Americans favor quality over quantity in pursuit of longevity
-
Ford Trucks Partners with Argus Cyber Security to Meet Regulatory Requirements and Accelerate Time-to-Market
-
Sunoco LP Completes Acquisition of European Liquid Fuels Terminals and Divestiture of West Texas Assets; Reaffirms 2024 Adjusted EBITDA Guidance Range
-
Ceva, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call
-
Wall Recycling Announces Sale of Scrap Metal Division to Foss Recycling
-
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
-
Canadian Solar Earns EcoVadis Silver Sustainability Rating
-
Keeper Security Empowers Users with Integrated Passphrase Generator
-
Qstream Launches AI Microlearning Content Generator To Increase Efficiencies For Training Teams
-
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003
-
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
-
Virtuous Continues Strong Growth and Momentum in Q1 2024
-
HundredX Partners with Forbes to Create 2024 Best Brands for Social Impact Rankings
-
Canaan Adds Accomplished Executive and Scientist, Uwe Schoenbeck, Ph.D., Along with New Capital, to Bolster its Biopharma Investment Efforts
-
RADCOM to Host First Quarter 2024 Conference Call and Webcast on Wednesday, May 15, 2024, at 8:00 AM

